Back
Rocket Pharmaceuticals Stock Price Chart
Sponsored
RCKT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
RCKT
Rocket Pharmaceuticals
Last Price:
14.09
Seasonality Move:
13.34%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rocket Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.9 | Buy |
20-day SMA: | 15.79 | Sell |
50-day SMA: | 17.17 | Sell |
200-day SMA: | 21.87 | Sell |
8-day EMA: | 14.06 | Buy |
20-day EMA: | 15.3 | Sell |
50-day EMA: | 16.83 | Sell |
200-day EMA: | 20.2 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.13 | Sell |
Relative Strength Index (14 RSI): | 37.41 | Sell |
Chaikin Money Flow: | 1084581 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.48 - 17.76) | Sell |
Bollinger Bands (100): | (16.17 - 21.73) | Sell |
Rocket Pharmaceuticals Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 14.11 while RCKT 8-day simple moving average is 13.90, which is a Buy signal.
- The stock price of RCKT is 14.11 while Rocket Pharmaceuticals 20-day SMA is 15.79, which makes it a Sell.
- Rocket Pharmaceuticals 50-day simple moving average is 17.17 while RCKT share price is 14.11, making it a Sell technically.
- RCKT stock price is 14.11 and Rocket Pharmaceuticals 200-day simple moving average is 21.87, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
43
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Sell
The current Rocket Pharmaceuticals [RCKT] share price is $14.11. The Score for RCKT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
1.29B
Price in USD:
14.11
Share Volume:
1.19M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
12.62
Sell
43
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 14.11 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 14.11 while RCKT 8-day exponential moving average is 14.06, which is a Buy signal.
- The stock price of RCKT is 14.11 while Rocket Pharmaceuticals 20-day EMA is 15.30, which makes it a Sell.
- Rocket Pharmaceuticals 50-day exponential moving average is 16.83 while RCKT share price is 14.11, making it a Sell technically.
- RCKT stock price is 14.11 and Rocket Pharmaceuticals 200-day simple moving average is 20.20, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.27 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is -1.13, suggesting Rocket Pharmaceuticals is a Sell
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 37.41, which suggest Rocket Pharmaceuticals is oversold
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (14.48 - 17.76), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (16.17 - 21.73), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.